Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Board of Appeals upholds planning commission's denial of Green Cross dispensary after hours of testimony

San Francisco Board of Appeals · October 25, 2006
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

After more than three hours of testimony and dozens of public speakers, the San Francisco Board of Appeals sustained the planning commission's denial of Green Cross's permit to operate a medical cannabis dispensary at 2701 Leavenworth by a 2'to'2 tie, leaving the disapproval in place.

The San Francisco Board of Appeals on Oct. 19 sustained the Planning Commission's denial of a permit for Green Cross to operate a medical cannabis dispensary at 2701 Leavenworth, after hours of testimony from city staff, legal counsel and more than 150 members of the public.

The board heard presentations from Lawrence Badner, the city's zoning administrator, who explained that although the planning staff did not find the proposed location legally prohibited under the code as currently interpreted, the Planning Commission had concluded exceptional and extraordinary circumstances existed in the area (including the district's tourist orientation and nearby child-focused programs) and voted to deny discretionary review. Joe Elford, attorney for Green Cross and appellant Kevin Reed, urged the board to overrule that decision and grant a conditional permit so the dispensary could demonstrate compliance with neighborhood conditions.

Why it matters: The Green Cross appeal tested how San Francisco's new medical cannabis rules…

Already have an account? Log in

Subscribe to keep reading

Unlock the rest of this article — and every article on Citizen Portal.

  • Unlimited articles
  • AI-powered breakdowns of topics, speakers, decisions, and budgets
  • Instant alerts when your location has a new meeting
  • Follow topics and more locations
  • 1,000 AI Insights / month, plus AI Chat
30-day money-back on paid plans